INIS
mutations
100%
cancer
67%
carriers
65%
risks
54%
breasts
51%
genes
37%
females
30%
genetics
30%
ovaries
30%
phenotype
25%
patients
19%
proteins
18%
genotype
17%
males
13%
data
12%
hazards
11%
fingers
11%
humans
10%
defects
10%
nucleotides
9%
spectra
8%
detection
7%
receptors
7%
evaluation
7%
children
7%
zinc
6%
adults
6%
splicing
6%
modifications
6%
efficiency
6%
Keyphrases
BRCA2 mutation
42%
BRCA1, BRCA2
42%
Breast Cancer Risk
38%
BRCA2
30%
BRCA mutation Carriers
28%
Breast Cancer
24%
Intellectual Disability
24%
Breast Cancer Susceptibility Gene 1 (BRCA1)
23%
Mutation Carriers
19%
Rett Syndrome
18%
Ovarian Cancer Risk
18%
Hazard Ratio
14%
Single nucleotide Polymorphism
14%
Ovarian Cancer
13%
Prader-Willi Syndrome
12%
X-linked Intellectual Disability
12%
Genome-wide Association Study
10%
Confidence Interval
10%
SNP
9%
Cancer Risk
8%
X-linked
8%
De-novo mutations
7%
Pathogenic Variants
7%
Common Genetic Variants
7%
Penetrance
6%
Methyl-CpG-binding Protein 2 (MeCP2)
6%
Missense Variants
6%
Clinical Genetics
6%
Syndromic
6%
Family History
6%
Biochemistry, Genetics and Molecular Biology
BRCA1
55%
BRCA2
46%
Intellectual Disability
26%
Allele
17%
Missense
14%
Genetics
13%
Genotyping
13%
Single-Nucleotide Polymorphism
12%
Rett Syndrome
12%
Cohort Study
12%
Exome Sequencing
10%
Genome-Wide Association Study
9%
Penetrance
8%
Genetic Divergence
7%
Single Nucleotide Polymorphism
7%
Gene Mutation
7%
Mosaicism
6%
Zebra Fish
6%
Cognition
6%
Binding Protein
6%
FMR1
6%
Phylogeny
6%
DNA Modification
6%
Telomere Length
6%
Ubiquitin-Conjugating Enzyme
6%
Wnt Signaling Pathway
6%
XRCC1
6%
Krüppel
6%
RNA Splicing
6%
Mitochondrial Haplogroup
6%
